147 related articles for article (PubMed ID: 22971323)
1. Empiric deworming to delay HIV disease progression in adults with HIV who are ineligible for initiation of antiretroviral treatment (the HEAT study): a multi-site, randomised trial.
Walson J; Singa B; Sangaré L; Naulikha J; Piper B; Richardson B; Otieno PA; Mbogo LW; Berkley JA; John-Stewart G
Lancet Infect Dis; 2012 Dec; 12(12):925-32. PubMed ID: 22971323
[TBL] [Abstract][Full Text] [Related]
2. Antihelminthics in helminth-endemic areas: effects on HIV disease progression.
Means AR; Burns P; Sinclair D; Walson JL
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD006419. PubMed ID: 27075622
[TBL] [Abstract][Full Text] [Related]
3. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial.
Walson JL; Otieno PA; Mbuchi M; Richardson BA; Lohman-Payne B; Macharia SW; Overbaugh J; Berkley J; Sanders EJ; Chung MH; John-Stewart GC
AIDS; 2008 Aug; 22(13):1601-9. PubMed ID: 18670219
[TBL] [Abstract][Full Text] [Related]
4. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.
Grinsztejn B; Hosseinipour MC; Ribaudo HJ; Swindells S; Eron J; Chen YQ; Wang L; Ou SS; Anderson M; McCauley M; Gamble T; Kumarasamy N; Hakim JG; Kumwenda J; Pilotto JH; Godbole SV; Chariyalertsak S; de Melo MG; Mayer KH; Eshleman SH; Piwowar-Manning E; Makhema J; Mills LA; Panchia R; Sanne I; Gallant J; Hoffman I; Taha TE; Nielsen-Saines K; Celentano D; Essex M; Havlir D; Cohen MS;
Lancet Infect Dis; 2014 Apr; 14(4):281-90. PubMed ID: 24602844
[TBL] [Abstract][Full Text] [Related]
5. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial.
Reynolds SJ; Makumbi F; Newell K; Kiwanuka N; Ssebbowa P; Mondo G; Boaz I; Wawer MJ; Gray RH; Serwadda D; Quinn TC
Lancet Infect Dis; 2012 Jun; 12(6):441-8. PubMed ID: 22433279
[TBL] [Abstract][Full Text] [Related]
6. Deworming helminth co-infected individuals for delaying HIV disease progression.
Walson JL; Herrin BR; John-Stewart G
Cochrane Database Syst Rev; 2009 Jul; (3):CD006419. PubMed ID: 19588389
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial.
Laurent C; Kouanfack C; Laborde-Balen G; Aghokeng AF; Mbougua JB; Boyer S; Carrieri MP; Mben JM; Dontsop M; Kazé S; Molinari N; Bourgeois A; Mpoudi-Ngolé E; Spire B; Koulla-Shiro S; Delaporte E;
Lancet Infect Dis; 2011 Nov; 11(11):825-33. PubMed ID: 21831714
[TBL] [Abstract][Full Text] [Related]
8. Can deworming delay immunosuppression in HIV?
Mkhize-Kwitshana ZL; Mabaso MH
Lancet Infect Dis; 2012 Dec; 12(12):899-900. PubMed ID: 22971324
[No Abstract] [Full Text] [Related]
9. Prevalence and correlates of helminth co-infection in Kenyan HIV-1 infected adults.
Walson JL; Stewart BT; Sangaré L; Mbogo LW; Otieno PA; Piper BK; Richardson BA; John-Stewart G
PLoS Negl Trop Dis; 2010 Mar; 4(3):e644. PubMed ID: 20361031
[TBL] [Abstract][Full Text] [Related]
10. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
Molina JM; Grund B; Gordin F; Williams I; Schechter M; Losso M; Law M; Ekong E; Mwelase N; Skoutelis A; Wiselka MJ; Vandekerckhove L; Benfield T; Munroe D; Lundgren JD; Neaton JD;
Lancet HIV; 2018 Apr; 5(4):e172-e180. PubMed ID: 29352723
[TBL] [Abstract][Full Text] [Related]
11. Combined effectiveness of anthelmintic chemotherapy and WASH among HIV-infected adults.
Means AR; van Lieshout L; Brienen E; Yuhas K; Hughes JP; Ndungu P; Singa B; Walson JL
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0005955. PubMed ID: 29346385
[TBL] [Abstract][Full Text] [Related]
12. Effect of point-of-care CD4 cell count results on linkage to care and antiretroviral initiation during a home-based HIV testing campaign: a non-blinded, cluster-randomised trial.
Desai MA; Okal DO; Rose CE; Ndivo R; Oyaro B; Otieno FO; Williams T; Chen RT; Zeh C; Samandari T
Lancet HIV; 2017 Sep; 4(9):e393-e401. PubMed ID: 28579225
[TBL] [Abstract][Full Text] [Related]
13. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
Lingappa JR; Baeten JM; Wald A; Hughes JP; Thomas KK; Mujugira A; Mugo N; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Magaret AS; Wang RS; Kidoguchi L; Barnes L; Ridzon R; Corey L; Celum C;
Lancet; 2010 Mar; 375(9717):824-33. PubMed ID: 20153888
[TBL] [Abstract][Full Text] [Related]
14. Effect of deworming on Th2 immune response during HIV-helminths co-infection.
Mulu A; Anagaw B; Gelaw A; Ota F; Kassu A; Yifru S
J Transl Med; 2015 Jul; 13():236. PubMed ID: 26187732
[TBL] [Abstract][Full Text] [Related]
15. A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
Miller WC; Hoffman IF; Hanscom BS; Ha TV; Dumchev K; Djoerban Z; Rose SM; Latkin CA; Metzger DS; Lancaster KE; Go VF; Dvoriak S; Mollan KR; Reifeis SA; Piwowar-Manning EM; Richardson P; Hudgens MG; Hamilton EL; Sugarman J; Eshleman SH; Susami H; Chu VA; Djauzi S; Kiriazova T; Bui DD; Strathdee SA; Burns DN
Lancet; 2018 Sep; 392(10149):747-759. PubMed ID: 30191830
[TBL] [Abstract][Full Text] [Related]
16. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial.
Parkes-Ratanshi R; Wakeham K; Levin J; Namusoke D; Whitworth J; Coutinho A; Mugisha NK; Grosskurth H; Kamali A; Lalloo DG;
Lancet Infect Dis; 2011 Dec; 11(12):933-41. PubMed ID: 21982529
[TBL] [Abstract][Full Text] [Related]
17. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
18. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial.
Raffi F; Jaeger H; Quiros-Roldan E; Albrecht H; Belonosova E; Gatell JM; Baril JG; Domingo P; Brennan C; Almond S; Min S;
Lancet Infect Dis; 2013 Nov; 13(11):927-35. PubMed ID: 24074642
[TBL] [Abstract][Full Text] [Related]
19. Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy.
Lankowski AJ; Tsai AC; Kanyesigye M; Bwana M; Haberer JE; Wenger M; Martin JN; Bangsberg DR; Hunt PW; Siedner MJ
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3036. PubMed ID: 25101890
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
